by Doug Donovan, Johns Hopkins University Credit: Pixabay/CC0 Public Domain It’s shaping up to be a big week for news on two eagerly awaited developments involving Pfizer’s COVID-19 vaccine: Booster shots and progress toward its first doses for children as young as five. The Food and Drug Administration is set to decide whether to accept its...
